Frontiers | Prognostic Models for Patients With Gleason Score 9 Prostate Cancer: A Population-Based Study
The Rotterdam Prostate Cancer Risk Calculator decision tree. PSA:... | Download Scientific Diagram
Estimation of life expectancy for newly diagnosed men with prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
Web tool gives individual prognosis for prostate cancer patients | CRUK CC
JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
Metastatic Prostate Cancer Prognosis Calculator
About prostate cancer - Diagnolita
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol | BMJ Open
Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer - European Urology Focus
Matrix table based on the validated ERSPC-based Rotterdam prostate... | Download Scientific Diagram
Indonesian prostate cancer risk calculator (IPCRC) | Download Scientific Diagram
Predicting Life Expectancy in Men Diagnosed with Prostate Cancer - ScienceDirect
Prostate Cancer Calculators
Prostate Cancer Calculators
CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK
Prostate Cancer Calculators
Tool helps predict who will respond best to targeted prostate cancer therapy | UCLA
Cancers | Free Full-Text | Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis
Prostate Cancer Screening and Diagnosis (September 2022) | Online Health Talk - YouTube
A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer - European Urology Oncology
Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients | Scientific Reports
Deciding on treatment for prostate cancer 2018
Next-generation prostate cancer risk calculator for primary care physicians. | Semantic Scholar
